A Safety and Dose-Finding Study of SYNT001 in Subjects With Pemphigus (Vulgaris or Foliaceus)
Clinical trial NCT03075904 · TERMINATED
Trial details
- NCT number
- NCT03075904
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-18
- Primary completion
- 2019-01-16
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.